Peptide Hormones Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Type (Follicle-stimulating Hormone and Luteinizing Hormone, Adrenocorticotropic Hormone, Growth Hormones, Erythropoietin, Insulin); Route of Administration (Parenteral, Oral, Mucosal, Pulmonary, Others), and Geography
Peptide hormones are proteins whose molecules are peptides or proteins, respectively. These peptides activates steroid hormone synthesis at multiple sites in the body. Like all peptides and proteins, peptide hormones and protein hormones are synthesized in cells from amino acids as per the mRNA transcripts.
Increasing in demand for hormone therapy and advancements in the field of pharmaceuticals are likely to augment the growth of peptide hormones market over the years to come. Furthermore, focus of new entrants and established players in the emerging markets are expected to provide growth opportunities in the market.
The "Global Peptide Hormones Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Peptide hormones market with detailed market segmentation by, type and route of administration, and geography. The global peptide hormones market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading peptide hormones market players and offers key trends and opportunities in the market.
The global peptide hormones market is segmented on the basis of type and route of administration. Based on type, it is classified into follicle-stimulating hormone and luteinizing hormone, adrenocorticotropic hormone, growth hormones, erythropoietin, and insulin. Based on route of administration, it is divided into parenteral, oral, mucosal, pulmonary, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global peptide hormones market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Peptide hormones Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting peptide hormones market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the peptide hormones market in these regions.
Get more information on this report :
The report covers key developments in the peptide hormones market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from peptide hormones market are anticipated to lucrative growth opportunities in the future with the rising demand for Peptide hormones market in the global market. Below mentioned is the list of few companies engaged in the Peptide hormones Market.
The report also includes the profiles of key peptide hormones market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Boehringer Ingelheim GmbH
- Eli Lily and Company
- Innovate Biopharmaceuticals
- Merck KGaA
- Novo Nordisk
- Pfizer, Inc.
- F. Hoffman-La-Roche Ltd.
- Tarix Pharmaceuticals
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization `options in the existing study.
Get more information on this report :
The List of Companies
2. Boehringer Ingelheim GmbH
3. Eli Lily and Company
4. Innovate Biopharmaceuticals
5. Merck KGaA
6. Novo Nordisk
7. Pfizer, Inc.
8. F. Hoffman-La-Roche Ltd.
10. Tarix Pharmaceuticals